Image

    Early Real-World Experience With Baricitinib in the Treatment of Severe Alopecia Areata

    September 2023 in “ Journal of The American Academy of Dermatology ”
    Maria-Angeliki Gkini, Panagiota Tagka, Theofanis Rigatos, Markos Papakonstantis
    Studysummary This announcement discusses the recent FDA approval of baricitinib for treating severe alopecia areata in adults and reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on jaad.org →
    Discuss this study in the Community →

    Related research 8

    1. Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata JAAD case reports · 2021
    2. Efficacy of Systemic Minoxidil and Tofacitinib Combination in Treatment-Resistant Alopecia Universalis Journal of Cosmetic Dermatology · 2020
    3. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    4. Topical and Intralesional Therapies for Alopecia Areata Dermatologic therapy · 2011
    5. Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases Dermatologic Therapy · 2011
    6. Alopecia Areata: Evidence-Based Treatments Seminars in cutaneous medicine and surgery · 2009
    7. Diagnosis of Hair Loss: Clinical Features of Common Causes PubMed · 1992
    8. Diagnosis and Management of the Hair Loss Patient PubMed · 1987